TrialJournal of geriatric oncology2022

SWOG 1918: A phase II/III randomized study of R-miniCHOP with or without oral azacitidine (CC-486) in participants age 75 years or older with newly diagnosed aggressive non-Hodgkin lymphomas - Aiming to improve therapy, outcomes, and validate a prospective frailty tool.

Elizabeth A Brem et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.